CLEANClean Science and Technology Limited
Chemicals · Specialty Chemicals · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Clean Science and Technology Limited, together with its subsidiaries, manufactures fine and specialty chemicals in India, China, the Americas, Europe, and internationally. It operates through Performance Chemicals, FMCG Chemicals, and Pharmaceutical & Agro Intermediates segments. The company offers performance chemicals, including monomethyl ether of hydroquinone, butylated hydroxy anisole, tertiary butyl hydroquinone, hindered amine light stabilisers, and butylated hydroxytoluene, as well as clean antiOX 962, 4-oxo tempo, 4-butoxy tempo, clean light stab 770, 4-hydroxy tempo, l-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, and dimethyl sebacate. It also provides FMCG chemicals, such as 4-methoxy acetophenone, anisole, guaiacol, butylated hydroxy anisole, l-ascorbyl palmitate, tertiary butyl hydroquinone, para di-methoxy benzene, and ortho methoxy toluene. In addition, the company offers pharmaceutical and agro intermediates, which include guaiacol, dicyclohexyl carbodiimide, veratrole, DHDT, para benzoquinone, para di-methoxy benzene, anisole, and ortho methoxy toluene. It exports its products and serves polymers, coatings, food, automotive, construction, cosmetics, personal care, fragrances, pharmaceuticals, agrochemical manufacturers, specialty chemical firms, and other industries. The company was incorporated in 2003 and is headquartered in Pune, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on CLEAN — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Overall evidence is weak (AlgoScore 37/100)
- • Profit growth: 4.7% YoY
- • PEG ratio: 7.50
- • RSI: 37
- • MACD: bearish
Bull case
- • ROCE: 17.5%
- • Debt/Equity: 0.00
- • Promoter holding: 55.2%
- • Golden cross setup: SMA50 above SMA200
Bear case
- • Profit growth: 4.7% YoY
- • PEG ratio: 7.50
- • RSI: 37
- • MACD: bearish
Key risks
- • Momentum is fading versus the broader market
- • Profit growth: 4.7% YoY
- • PEG ratio: 7.50
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹28.56). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.